<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0001634'>Mitral valve prolapse</z:hpo> (MVP) is a predisposing factor for <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>, especially in young adults </plain></SENT>
<SENT sid="1" pm="."><plain>Cerebral embolization of intracardiac <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e> is the probable mechanism in many cases </plain></SENT>
<SENT sid="2" pm="."><plain>Platelets play a key role in the development of <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>We found that platelet factor 4, a marker protein of platelet activation, was elevated in 12 of 33 MVP patients (36%) without a history of <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>This finding indicates that platelets are frequently activated in asymptomatic MVP patients and may allow identification of a subgroup of MVP patients with activated platelets who are at increased risk for emboli </plain></SENT>
</text></document>